Pre‐diagnostic circulating insulin‐like growth factor‐I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition

Previous in vitro and case–control studies have found an association between the insulin‐like growth factor (IGF)‐axis and bladder cancer risk. Circulating concentrations of IGF‐I have also been found to be associated with an increased risk of several cancer types; however, the relationship between...

Full description

Bibliographic Details
Main Authors: Lin, C, Travis, RC, Appleby, PN, Tipper, SJ, Weiderpass, E, Chang-Claude, J, Gram, IT, Kaaks, R, Kiemeney, LA, Ljungberg, B, Tumino, R, Tjønneland, A, Roswall, N, Overvad, K, Boutron-Ruault, M-C, Manciniveri, FR, Severi, G, Trichopoulou, A, Masala, G, Sacerdote, G, Agnoli, C, Panico, S, Bueno-de-Mesquita, B, Peeters, PH, Salamanca-Fernández, E, Chirlaque, M-D, Ardanaz, E, Dorronsoro, M, Menéndez, V, Luján-Barroso, L, Liedberg, F, Freisling, H, Gunter, M, Aune, D, Cross, AJ, Riboli, E, Key, TJ, Perez-Cornago, A
Format: Journal article
Published: Wiley 2018
_version_ 1797077605043666944
author Lin, C
Travis, RC
Appleby, PN
Tipper, SJ
Weiderpass, E
Chang-Claude, J
Gram, IT
Kaaks, R
Kiemeney, LA
Ljungberg, B
Tumino, R
Tjønneland, A
Roswall, N
Overvad, K
Boutron-Ruault, M-C
Manciniveri, FR
Severi, G
Trichopoulou, A
Masala, G
Sacerdote, G
Agnoli, C
Panico, S
Bueno-de-Mesquita, B
Peeters, PH
Salamanca-Fernández, E
Chirlaque, M-D
Ardanaz, E
Dorronsoro, M
Menéndez, V
Luján-Barroso, L
Liedberg, F
Freisling, H
Gunter, M
Aune, D
Cross, AJ
Riboli, E
Key, TJ
Perez-Cornago, A
author_facet Lin, C
Travis, RC
Appleby, PN
Tipper, SJ
Weiderpass, E
Chang-Claude, J
Gram, IT
Kaaks, R
Kiemeney, LA
Ljungberg, B
Tumino, R
Tjønneland, A
Roswall, N
Overvad, K
Boutron-Ruault, M-C
Manciniveri, FR
Severi, G
Trichopoulou, A
Masala, G
Sacerdote, G
Agnoli, C
Panico, S
Bueno-de-Mesquita, B
Peeters, PH
Salamanca-Fernández, E
Chirlaque, M-D
Ardanaz, E
Dorronsoro, M
Menéndez, V
Luján-Barroso, L
Liedberg, F
Freisling, H
Gunter, M
Aune, D
Cross, AJ
Riboli, E
Key, TJ
Perez-Cornago, A
author_sort Lin, C
collection OXFORD
description Previous in vitro and case–control studies have found an association between the insulin‐like growth factor (IGF)‐axis and bladder cancer risk. Circulating concentrations of IGF‐I have also been found to be associated with an increased risk of several cancer types; however, the relationship between pre‐diagnostic circulating IGF‐I concentrations and bladder cancer has never been studied prospectively. We investigated the association of pre‐diagnostic plasma concentrations of IGF‐I with risk of overall bladder cancer and urothelial cell carcinoma (UCC) in a case–control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. A total of 843 men and women diagnosed with bladder cancer between 1992 and 2005 were matched with 843 controls by recruitment centre, sex, age at recruitment, date of blood collection, duration of follow‐up, time of day and fasting status at blood collection using an incidence density sampling protocol. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using conditional logistic regression with adjustment for smoking status. No association was found between pre‐diagnostic circulating IGF‐I concentration and overall bladder cancer risk (adjusted OR for highest versus lowest fourth: 0.91, 95% CI: 0.66–1.24, ptrend = 0.40) or UCC (n of cases = 776; 0.91, 0.65–1.26, ptrend = 0.40). There was no significant evidence of heterogeneity in the association of IGF‐I with bladder cancer risk by tumour aggressiveness, sex, smoking status, or by time between blood collection and diagnosis (pheterogeneity > 0.05 for all). This first prospective study indicates no evidence of an association between plasma IGF‐I concentrations and bladder cancer risk.
first_indexed 2024-03-07T00:20:29Z
format Journal article
id oxford-uuid:7c611d7b-e610-4af8-9fc0-011543241c15
institution University of Oxford
last_indexed 2024-03-07T00:20:29Z
publishDate 2018
publisher Wiley
record_format dspace
spelling oxford-uuid:7c611d7b-e610-4af8-9fc0-011543241c152022-03-26T20:56:53ZPre‐diagnostic circulating insulin‐like growth factor‐I and bladder cancer risk in the European Prospective Investigation into Cancer and NutritionJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:7c611d7b-e610-4af8-9fc0-011543241c15Symplectic Elements at OxfordWiley2018Lin, CTravis, RCAppleby, PNTipper, SJWeiderpass, EChang-Claude, JGram, ITKaaks, RKiemeney, LALjungberg, BTumino, RTjønneland, ARoswall, NOvervad, KBoutron-Ruault, M-CManciniveri, FRSeveri, GTrichopoulou, AMasala, GSacerdote, GAgnoli, CPanico, SBueno-de-Mesquita, BPeeters, PHSalamanca-Fernández, EChirlaque, M-DArdanaz, EDorronsoro, MMenéndez, VLuján-Barroso, LLiedberg, FFreisling, HGunter, MAune, DCross, AJRiboli, EKey, TJPerez-Cornago, APrevious in vitro and case–control studies have found an association between the insulin‐like growth factor (IGF)‐axis and bladder cancer risk. Circulating concentrations of IGF‐I have also been found to be associated with an increased risk of several cancer types; however, the relationship between pre‐diagnostic circulating IGF‐I concentrations and bladder cancer has never been studied prospectively. We investigated the association of pre‐diagnostic plasma concentrations of IGF‐I with risk of overall bladder cancer and urothelial cell carcinoma (UCC) in a case–control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. A total of 843 men and women diagnosed with bladder cancer between 1992 and 2005 were matched with 843 controls by recruitment centre, sex, age at recruitment, date of blood collection, duration of follow‐up, time of day and fasting status at blood collection using an incidence density sampling protocol. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using conditional logistic regression with adjustment for smoking status. No association was found between pre‐diagnostic circulating IGF‐I concentration and overall bladder cancer risk (adjusted OR for highest versus lowest fourth: 0.91, 95% CI: 0.66–1.24, ptrend = 0.40) or UCC (n of cases = 776; 0.91, 0.65–1.26, ptrend = 0.40). There was no significant evidence of heterogeneity in the association of IGF‐I with bladder cancer risk by tumour aggressiveness, sex, smoking status, or by time between blood collection and diagnosis (pheterogeneity > 0.05 for all). This first prospective study indicates no evidence of an association between plasma IGF‐I concentrations and bladder cancer risk.
spellingShingle Lin, C
Travis, RC
Appleby, PN
Tipper, SJ
Weiderpass, E
Chang-Claude, J
Gram, IT
Kaaks, R
Kiemeney, LA
Ljungberg, B
Tumino, R
Tjønneland, A
Roswall, N
Overvad, K
Boutron-Ruault, M-C
Manciniveri, FR
Severi, G
Trichopoulou, A
Masala, G
Sacerdote, G
Agnoli, C
Panico, S
Bueno-de-Mesquita, B
Peeters, PH
Salamanca-Fernández, E
Chirlaque, M-D
Ardanaz, E
Dorronsoro, M
Menéndez, V
Luján-Barroso, L
Liedberg, F
Freisling, H
Gunter, M
Aune, D
Cross, AJ
Riboli, E
Key, TJ
Perez-Cornago, A
Pre‐diagnostic circulating insulin‐like growth factor‐I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition
title Pre‐diagnostic circulating insulin‐like growth factor‐I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition
title_full Pre‐diagnostic circulating insulin‐like growth factor‐I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition
title_fullStr Pre‐diagnostic circulating insulin‐like growth factor‐I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition
title_full_unstemmed Pre‐diagnostic circulating insulin‐like growth factor‐I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition
title_short Pre‐diagnostic circulating insulin‐like growth factor‐I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition
title_sort pre diagnostic circulating insulin like growth factor i and bladder cancer risk in the european prospective investigation into cancer and nutrition
work_keys_str_mv AT linc prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT travisrc prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT applebypn prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT tippersj prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT weiderpasse prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT changclaudej prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT gramit prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT kaaksr prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT kiemeneyla prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT ljungbergb prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT tuminor prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT tjønnelanda prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT roswalln prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT overvadk prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT boutronruaultmc prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT manciniverifr prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT severig prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT trichopouloua prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT masalag prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT sacerdoteg prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT agnolic prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT panicos prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT buenodemesquitab prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT peetersph prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT salamancafernandeze prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT chirlaquemd prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT ardanaze prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT dorronsorom prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT menendezv prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT lujanbarrosol prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT liedbergf prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT freislingh prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT gunterm prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT auned prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT crossaj prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT ribolie prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT keytj prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition
AT perezcornagoa prediagnosticcirculatinginsulinlikegrowthfactoriandbladdercancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition